NewslettersCancer Stem Cell NewsDermal Cell NewsMammary Cell NewsProstate Cell NewsPropanc Biopharma Receives Notice of Allowance for Proenzyme Compositions to Treat Cancer from the European Patent OfficeBy lbeveridge - August 18, 20220171Propanc Biopharma, Inc. today announced that a Notice of Allowance has been received from the European Patent Office for claims involving compositions of proenzymes to treat cancer.[Business Wire]Press Release